Company
Danaher
Official Name: Danaher Corporation
Headquarters: Washington, DC, United States
Founded: 1969
Employees: 78,000
CEO: Mr. Rainer M. Blair
Market Cap
$171.89 Billion
USD as of Jan. 1, 2024
Company Description
Danaher Corporation is a diversified multinational company providing professional, medical, industrial, and commercial products and services. It is especially involved in the design, manufacturing, and commercialization of medical and laboratory instruments for medical diagnosis, as well as specialized equipment, consumables, and software for the biopharmaceutical, packaging, food and beverage, aerospace, microelectronics, water utilities, and general industrial sectors.
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $207.62 B |
| Siemens Healthineers AG | $66.05 B |
| DexCom, Inc. | $46.50 B |
| IDEXX Laboratories, Inc. | $44.72 B |
| IQVIA Holdings Inc. | $40.16 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Danaher Corporation has the following listings and related stock indices.
Stock: NYSE: DHR wb_incandescent
Stock: BMV: DHR wb_incandescent
Stock: Bovespa: DHER34 wb_incandescent
Stock: FSX: DAP wb_incandescent
Stock: NYSE: DHR.PR.A wb_incandescent
Stock: NYSE: DHR.PR.B wb_incandescent
Stock: NYSE: DHR-A wb_incandescent
Stock: XETR: DAP wb_incandescent
Key People
Founder(s): Steven M. Rales, Mitchell Rales
Steven M. Rales, Chairman of the Board Mitchell Rales, Chairman of the Executive Committee Rainer M. Blair, President & CEO Daniel L. Comas, Executive VP & CFO
Financials
Revenue: US$29.453 billion (2021)
Operating income: US$3.27 billion (2019)
Net income: US$2.49 billion (2017)
Total assets: US$46.65 billion (2017)
Total equity: US$26.37 billion (2017)